INTEGRATED BIOPHARMA INC Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
INTEGRATED BIOPHARMA INC (INBP) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$18.00 thousand for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-15.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2023-09-15
- INTEGRATED BIOPHARMA INC valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2022-06-30 was -$598.00K.
- INTEGRATED BIOPHARMA INC valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2022-03-31 was -$52.00K.
- INTEGRATED BIOPHARMA INC valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2021-12-31 was $546.00K, a 28.77% increase year-over-year.
- INTEGRATED BIOPHARMA INC valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2021-09-30 was -$128.00K.
- INTEGRATED BIOPHARMA INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$18.00K, a 175.00% decline from fiscal 2022.
- INTEGRATED BIOPHARMA INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $24.00K, a 99.07% decline from fiscal 2021.
- INTEGRATED BIOPHARMA INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $2.58M.
- INTEGRATED BIOPHARMA INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was -$1.90M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month as first filed | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-06-30 | -$18.00K 10-K · filed 2023-09-15 | |||||
| 2022-06-30 | -$598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-15 | -$650.00K derived: sum of 2 quarters · filed 2023-09-15 | -$104.00K derived: sum of 3 quarters · filed 2023-09-15 | $24.00K 10-K · filed 2023-09-15 | $1.93M 10-K · filed 2022-09-13 | |
| 2022-03-31 | -$52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $494.00K derived: sum of 2 quarters · filed 2023-05-11 | $622.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $546.00K 10-Q · filed 2023-02-10 | $674.00K 10-Q · filed 2023-02-10 | ||||
| 2021-09-30 | -$128.00K 10-Q · filed 2022-11-10 | $128.00K 10-Q · filed 2021-11-10 | ||||
| 2021-06-30 | $2.58M 10-K · filed 2022-09-13 | -$2.58M 10-K · filed 2021-09-02 | ||||
| 2020-12-31 | $424.00K 10-Q · filed 2022-02-10 | |||||
| 2020-06-30 | -$1.90M 10-K · filed 2021-09-02 | |||||
| 2019-06-30 | -$541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | -$578.00K derived: sum of 2 quarters · filed 2020-09-23 | -$559.00K derived: sum of 3 quarters · filed 2020-09-23 | -$590.00K 10-K · filed 2020-09-23 | ||
| 2019-03-31 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15 | -$18.00K derived: sum of 2 quarters · filed 2019-05-15 | -$49.00K 10-Q · filed 2019-05-15 | -$37.00K derived: sum of 4 quarters · filed 2019-08-29 | ||
| 2018-12-31 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | -$12.00K 10-Q · filed 2019-02-13 | $0.00 derived: sum of 3 quarters · filed 2019-08-29 | -$43.00K derived: sum of 4 quarters · filed 2019-08-29 | ||
| 2018-09-30 | -$31.00K 10-Q · filed 2018-11-09 | -$19.00K derived: sum of 2 quarters · filed 2019-08-29 | -$62.00K derived: sum of 3 quarters · filed 2019-08-29 | -$363.00K derived: sum of 4 quarters · filed 2019-08-29 | ||
| 2018-06-30 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-29 | -$31.00K derived: sum of 2 quarters · filed 2019-08-29 | -$332.00K derived: sum of 3 quarters · filed 2019-08-29 | -$278.00K 10-K · filed 2019-08-29 | ||
| 2018-03-31 | -$43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15 | -$344.00K derived: sum of 2 quarters · filed 2019-05-15 | -$290.00K 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | -$301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | -$247.00K 10-Q · filed 2019-02-13 | ||||
| 2017-09-30 | $54.00K 10-Q · filed 2018-11-09 | |||||
| 2017-06-30 | -$1.32M 10-K · filed 2018-09-12 | |||||
| 2016-06-30 | -$114.00K 10-K · filed 2017-09-01 |